ON DEMAND WEBINAR
Duration: 45 minutes

Innovations in cancer therapy are everywhere. This activity is evident within immuno-oncology as new approaches, such as immune checkpoint inhibitors and CAR-T demonstrate their potential. Along with these opportunities come a wealth of challenges that could get in the way of delivering positive patient outcomes, including patient matching, finding actionable, meaningful insights, and access and cost.

Join BrightInsight CEO Kal Patel, M.D., along with Arturo Loaiza-Bonilla, M.D. of theCancer Treatment Centers of America, and John Lo, Senior VP, Worldwide Hematology of Bristol Myers Squibb as they explore how you can overcome these challenges using digital technologies to:

• Enable more targeted interventions through data
• Improve patient outcomes through precision medicine and better patient matching
• Expand patient access to therapies by easing barriers to clinical trial enrollment and reimbursement

SPEAKERS  

Kal Patel, M.D.
CEO and Co-Founder
BrightInsight

Arturo Loaiza-Bonilla, M.D.
MSEd, FACP
Cancer Treatment Centers of America

John Lo
Senior VP
Worldwide Hematology, BMS